2seventy bio, Inc. (TSVT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
60 Binney Street
Cambridge, MA 02142
United States of America (the)
Phone
339 499 9300
Website
Sector
Healthcare
Industry
Biotechnology
Employees
65
First IPO Date
November 03, 2021
| Name | Title | Pay | Year Born |
| William D. Baird | Chief Executive Officer, President & Director | 954,403 | 1972 |
| Victoria Eatwell | Chief Financial Officer | 598,670 | 1986 |
| Jessica Snow | Chief Operating Officer | 603,168 | 1979 |
2seventy bio, Inc. operates as a biotechnology firm specializing in cell and gene therapies, with a primary mission to discover, develop, and commercialize advanced cancer treatments within the U.S. Its pipeline notably includes idecabtagene vicleucel, marketed as ide-cel or Abecma, and bb21217, both of which are CAR-T cell therapeutic candidates specifically designed to address multiple myeloma. The company also maintains a strategic partnership with Bristol-Myers Squibb Company. Founded in 2021, its corporate headquarters are situated in Cambridge, Massachusetts.